Skip to content

Healing Hearts and Mending Minds in Older Adults Living With HIV

Healing Hearts and Mending Minds in Older Adults Living With HIV

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02711878
Acronym
FitBrain
Enrollment
115
Registered
2016-03-17
Start date
2016-09-30
Completion date
2019-12-20
Last updated
2023-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AIDS, Cardiovascular Disease, HIV

Brief summary

The purpose of this study is to see if exercise is helpful for improving memory, concentration thinking abilities, physical function, and quality of life for adults aged 50 to 89 years living with HIV and who have two or more cardiovascular disease risk factors. The study will test two kinds of intervention exercises: one group will walk for exercise and the second group will stretch for exercise. Members of both interventions will be asked to participate in one-on-one interviews/assessments, measures of physical functioning, and some sessions with others who are also enrolled in the study.

Detailed description

This is a two arm, randomized controlled trial to test the longitudinal effects of the Let's Move Program (walking for exercise) compared to effects of the attention control Let's Flex Program (stretching for exercise) in participants aged 50 to 89 years living with HIV and who have two or more cardiovascular disease risk factors. Participants in both interventions will be asked to participate in one-on-one interviews/assessments, measures of physical functioning, and some sessions with others who are also enrolled in the study. Participants will participate in an in home exercise program for twelve weeks in which the study team will help identify maximum duration and intensity followed by a maintenance period for weeks 13-58.

Interventions

Participants will be asked to walk five times per week for twelve weeks for a minimum of 30 minutes while wearing a heart rate monitor and a pedometer. Participants will also receive weekly telephone calls from a member of the research team to monitor walking progress and to change walking duration or intensity level based on their progress.After the twelve week period, participants will enter a maintenance exercise phase for weeks 13-17 in which they will be asked to maintain their exercise regimen.

BEHAVIORALLet's Flex Program

Participants will be asked to stretch five times per week for twelve weeks for a minimum of 30 minutes. Participants will also receive weekly telephone calls from a member of the research team to monitor progress and to change duration or intensity level based on their progress.After the twelve week period, participants will enter a maintenance exercise phase for weeks 13-17 in which they will be asked to maintain their exercise regimen.

Participants will attend four separate group intervention sessions for 2.5 hours for four consecutive weeks at the beginning of the program. Groups will consist of 6-8 members and will focus on the rationale for aerobic exercise, barriers to exercise, finding time for exercise, how to set short and long term exercise goals, and use of self-monitoring to improve exercise engagement.

Sponsors

National Institute of Nursing Research (NINR)
CollaboratorNIH
Emory University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* HIV diagnosis * English speaking * Live independently within a 30-45 mile radius of Atlanta, Georgia * Not involved in any structured exercise program or exercising 3 or more times per week for a minimum of 30 minutes * Not involved in any weight loss program * Not hospitalized within the last 60-days * Clinically stable and on antiretroviral therapy (ART) 6 months before enrollment * If taking statins, stable on medication for 3 months * Score 3 or less on the verbal memory subtest of the Montreal Cognitive Assessment (MoCA) * Less than 0.5 standard deviations (SD) below mean on the Oral Trail Making Test B * Able to provide informed consent and pass a consent post-test

Exclusion criteria

* Non sedentary (defined as engaging in \> 30 minutes of moderately strenuous exercise 3 times or more a week) * Medical or physical condition that would preclude participation in the exercise component of the study (e.g., severe arthritis or mobility problems, lower extremity amputations, joint replacement(s), balance disorders, dizziness, dyspnea on exertion (DOE) with moderate exertion, difficulty walking one block, recent falls, obvious injury to lower extremity, uncontrolled hypertension or diabetes, renal failure, blindness, or a history of angina with activity) * Ischemic changes or inappropriate BP changes on baseline exercise (modified Balke or Bruce) treadmill test * On oral corticosteroids (nasal, optical and inhaler corticosteroids allowed without restriction) , experiencing acute inflammation at time of baseline or follow-up testing (this will result in rescheduling of testing if no other

Design outcomes

Primary

MeasureTime frameDescription
NIH ToolboxBaseline, Post Intervention (Up to 58 weeks)Computerized cognitive tests developed and distributed by the NIH. Tests include Pattern Comparison Processing Speed Test, Picture Vocabulary Test, Reading Recognition Test, Dimensional Change Card Sort Test, Flanker Inhibitory Control and Attention Test, Picture Sequence Memory Test, List Sorting Working Memory Test, and Oral Symbol Digit Test
Letter Fluency Assessed by Change in FAS Test ScoreBaseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 ( 56-58 weeks post baseline)The FAS test requires stating out loud as many words that begin with the assigned letter (F, A, and S) as possible within 60-seconds. Results represent total number of words stated for F,A & S combined.
Category Fluency Test ScoreBaseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 ( 56-58 weeks post baseline)The category fluency test requires participants to state out load the names of as many animals as possible within 60-seconds. Results are total number of animals named.
Hopkins Verbal Learning Test (HVLT) - Revised ScoreBaseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 ( 56-58 weeks post baseline)The HVLT-Revised is a list learning task requiring the respondent to recall as many words as possible from a list of 12 words provided orally by the examiner. There is a learning trial, a delayed recall trial, and a recognition trial. Results show HVLT Total recall (Total number if words recalled over 3 trials) and HVLT Delayed recall (Total number of words recalled after 25 minute delay).
Brief Visual Memory Test - Revised (BVMT-R) ScoreBaseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 ( 56-58 weeks post baseline)The Brief Visual Memory Test is a performance based test that requires that participants reproduce simple visual images from memory (the images are displayed for 10 seconds then removed from view). The BVMT-R contains a learning trial, a recall trial, a recognition trial, and a copy trial. Each figure recalled is given 0,1, or 2 points based on accuracy and location recall. Results show BVMT Total recall (Total number if figures recalled over 3 trials: range 0 - 36) and BVMT delayed recall (total number of figures recalled after 25 min delay. Score range 0-12). Higher score correlate with better outcome.
Grooved Pegboard Test ScoreBaseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 ( 56-58 weeks post baseline)The Grooved Pegboard Test requires the placing of grooved pegs into a same-shaped hole as quickly as possible, once with the dominant hand and once with the non-dominant hand.
Finger Tapping Test ScoreBaseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 ( 56-58 weeks post baseline)The finger tapping test a fine motor speed requires tapping a lever with the index finger as quickly as possible. Trials with the dominant and non-dominant hand are completed.
Coding Test ScoreBaseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 ( 56-58 weeks post baseline)The coding test requires writing the corresponding symbol associated with a letter from a key provided. As many responses as possible are completed in the 120 second time limit. Results presented are the total number of correct responses (possible score range 0-135).
Digit Span Test ScoreBaseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 ( 56-58 weeks post baseline)The digit span test is a performance based test that requires repeating an increasing span of digits that are provided verbally by the examiner. The test includes trials of repeating digits in the same order presented by the examiner, in the reverse order of that presented by the examiner, and in ascending sequence. Scores range from 0 to 48. Higher score correlates with better outcome.
Symbol Span Test ScoreBaseline, 3 months, 6 months and 12 months Post InterventionThe subtest assesses visual working memory using novel visual stimuli. A series of abstract symbols on a page are shown briefly. Then the symbols are to be selected from an array of symbols in the same order they were presented on the previous page. This performance based test measures storage and manipulation of visual details in working memory. Score range from 0-36. Higher score correlates with better outcome.
Instrumental Activities of Daily Living (IADL) Test ScoreBaseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 (56-58 weeks post baseline)The Instrumental Activities of Daily Living (IADL) Test is a self-report measure assessing the amount of assistance, if any, required to do day-to-day tasks necessary to live independently. A summary score ranges from 0 (low function, dependent) to 8 (high function, independent) for women and 0 through 5 for men to avoid potential gender bias). Higher scores indicate worse performance in instrumental activities activities of daily living.
Stroop Color and Word Test ScoreBaseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 ( 56-58 weeks post baseline)The Stroop Color and Word Test is a performance-based test of executive function and inhibitory responding. The participant is presented with a page with the words red, blue, and green printed 100 times in (20 words in 5 columns). Each word is printed in a different color of ink than the target word (e.g, the word red is printed in blue ink). Participants read the color of ink in which the word is printed as quickly are possible within a time limit. The correct number within the time limit is the score. Raw scores (unadjusted for age and education) range from 0-100.
Trail Making Test ScoreBaseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 ( 56-58 weeks post baseline)The Trail Making Test is a performance based test of visual attention and task switching. It consists of two parts in which the subject is instructed to connect circles as possible while still maintaining accuracy. Trails A subtest requires the connection in sequence of 25 circles labeled by numbers. Trails B requires the connection in sequence of 25 circles labeled by alternating numbers and letters (1-A-2-B-3-C). The score on the test is the time in seconds that it takes to complete. Higher scores (i.e., time) indicate poorer performance.

Secondary

MeasureTime frameDescription
Interleukin 6 (IL-6) LevelBaseline, T1 (13-15 Weeks), T2 (28-30 weeks), T3 (56-58 weeks)IL-6 is a pro-inflammatory cytokine known to contribute to the pathogenesis of risk of cardiovascular disease (CVD) and cognitive impairment (CI) through inflammation and promotion of endothelial vascular dysfunction. IL-6 is measured by enzyme-linked immunosorbent assay (ELISA) and reported as in picograms per deciliter (pg/dL). Higher concentrations of IL-6 raise congenital heart defect risk.
Tumor Necrosis Factor Alpha (TNF-alpha) LevelBaseline, T1 (13-15 wks), T2 (28-30 wks), T3 (56-58 wks)TNFR1 membrane bound receptors that have been shown to bind TNF alpha. Activation of TNFR1 mediates the proinflammatory properties of TNF alpha.
Brain-derived Neurotrophic Factor (BDNF) LevelBaseline, Post Intervention (Up to 58 weeks)BDNF is a protein that occurs naturally in the hippocampus, cortex, and basal forebrain-areas vital to learning, memory, and higher thinking; an increase in BDNF in animal models and humans is thought to enhance neurogenesis. BDNF is reported as in picogram per milliliter (pg/mL).
Flow-Mediated Dilatation (FMD)Baseline, T2 (28-30 weeks post baseline)Flow-mediated dilatation (FMD) is a measure of endothelial function; the measure of % FMD at 60 seconds reflects arterial relaxation time after cuff deflation.
Soluble Cluster of Differentiation 14 (sCD14) LevelBaseline, T1 (13-15 weeks), T2 (28-30 weeks), T3 (56 -58 weeks)Soluble Cluster of Differentiation 14 (sCD14) is a marker of monocyte activation, is associated with neurocognitive impairment and HIV-associated neurocognitive disorders (HANDs) and higher mortality in persons living with HIV.

Other

MeasureTime frameDescription
Pittsburgh Sleep Quality Index (PSQI) ScoreBaseline, T2 (28-30 weeks post baseline), T3 (56-58 weeks post baseline)The Pittsburgh Sleep Quality Index (PSQI) is a 19-item measure of the quality and patterns of sleep among adults. Scoring is based on a 0 to 3 Likert scale. The global score is 21; total possible score ranges from 0 to 21. The higher the score the worse the sleep quality.
Exercise Regimen as Assessed by the Community Healthy Activities Model Program for Seniors (CHAMPS) QuestionnaireBaseline, T2 (28-30 weeks post baseline), T3 (56-58 weeks post baseline)The 41-item Community Healthy Activities Model Program for Seniors evaluates weekly duration of various types of physical activity among older adults including light, moderate and vigorous intensity levels. The activity is assessed by hours per week using 6 categories less than 1 hour to 9 or more hours. The values presented below are hours participants indicated they spent in moderate intensity activity levels at the 3 time points over the past 4 weeks. Guidelines suggest 150 minutes (2.5 hours) per week in moderate intensity physical activity, below this number is considered sedentary. We measure change from baseline in time spent in moderate intensity exercise.
V02 Max RateBaselineV02 max is the maximum rate of oxygen consumption as measured during incremental exercise using the Balke treadmill test. This is an exploratory outcome.
Six-minute Walk TestBaseline, T2 (28-30 weeks post baseline), T3 (56-58 weeks post baseline)Measure of functional capacity or submaximal exercise. Scores reflect distance walked in feet for 6 minutes duration. This is an exploratory outcome.
Beck Depression Inventory-II (BDI-II) ScoreBaseline, T2 (28-30 weeks post baseline), T3 (56-58 weeks post baseline)BDI-II is a 21-question multiple-choice self-report inventory, one of the most widely used instruments for measuring the severity of depression. Each answer being scored on a scale value of 0 to 3. Scores range from 0-63. Interpretation: 0 through 9 indicate no or minimal depression; scores from 10 through 18 indicate mild to moderate depression; scores from 19 through 29 indicate moderate to severe depression; and scores from 30 through 63 indicate severe depression.

Countries

United States

Participant flow

Recruitment details

Participants were enrolled between September 2016 and December 2018.

Participants by arm

ArmCount
Let's Move Program
Participants in this group will be asked to walk five times per week for twelve weeks for a minimum of 30 minutes in their home while wearing a heart rate monitor and a pedometer. Participants will then enter a maintenance exercise period for 65 weeks. Let's Move Program: Participants will be asked to walk five times per week for twelve weeks for a minimum of 30 minutes while wearing a heart rate monitor and a pedometer. Participants will also receive weekly telephone calls from a member of the research team to monitor walking progress and to change walking duration or intensity level based on their progress.After the twelve week period, participants will enter a maintenance exercise phase for weeks 13-17 in which they will be asked to maintain their exercise regimen. Group Motivational Interviewing: Participants will attend four separate group intervention sessions for 2.5 hours for four consecutive weeks at the beginning of the program. Groups will consist of 6-8 members and will focus on the rationale for aerobic exercise, barriers to exercise, finding time for exercise, how to set short and long term exercise goals, and use of self-monitoring to improve exercise engagement.
76
Let's Flex Program
Participants in this group will be asked to stretch five times per week for twelve weeks for a minimum of thirty minutes in their home. Participants will then enter a maintenance exercise period for 65 weeks. Let's Flex Program: Participants will be asked to stretch five times per week for twelve weeks for a minimum of 30 minutes. Participants will also receive weekly telephone calls from a member of the research team to monitor progress and to change duration or intensity level based on their progress.After the twelve week period, participants will enter a maintenance exercise phase for weeks 13-17 in which they will be asked to maintain their exercise regimen. Group Motivational Interviewing: Participants will attend four separate group intervention sessions for 2.5 hours for four consecutive weeks at the beginning of the program. Groups will consist of 6-8 members and will focus on the rationale for aerobic exercise, barriers to exercise, finding time for exercise, how to set short and long term exercise goals, and use of self-monitoring to improve exercise engagement.
39
Total115

Baseline characteristics

CharacteristicLet's Flex ProgramTotalLet's Move Program
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
1 Participants4 Participants3 Participants
Age, Categorical
Between 18 and 65 years
38 Participants111 Participants73 Participants
Age, Continuous53.92 years
STANDARD_DEVIATION 5.2
55.09 years
STANDARD_DEVIATION 5.2
55.68 years
STANDARD_DEVIATION 5.2
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Black or African American
37 Participants100 Participants63 Participants
Race (NIH/OMB)
More than one race
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants1 Participants
Race (NIH/OMB)
White
2 Participants12 Participants10 Participants
Region of Enrollment
United States
39 Participants115 Participants76 Participants
Sex: Female, Male
Female
20 Participants46 Participants26 Participants
Sex: Female, Male
Male
19 Participants69 Participants50 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 760 / 39
other
Total, other adverse events
0 / 760 / 39
serious
Total, serious adverse events
0 / 760 / 39

Outcome results

Primary

Brief Visual Memory Test - Revised (BVMT-R) Score

The Brief Visual Memory Test is a performance based test that requires that participants reproduce simple visual images from memory (the images are displayed for 10 seconds then removed from view). The BVMT-R contains a learning trial, a recall trial, a recognition trial, and a copy trial. Each figure recalled is given 0,1, or 2 points based on accuracy and location recall. Results show BVMT Total recall (Total number if figures recalled over 3 trials: range 0 - 36) and BVMT delayed recall (total number of figures recalled after 25 min delay. Score range 0-12). Higher score correlate with better outcome.

Time frame: Baseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 ( 56-58 weeks post baseline)

Population: Some participants did not complete the form or completed the incorrect forms and could not be included in the analysis.

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramBrief Visual Memory Test - Revised (BVMT-R) ScoreTotal recall - T2 (28-30 weeks post baseline)19.59 number of correct figures recalledStandard Deviation 6.78
Let's Move ProgramBrief Visual Memory Test - Revised (BVMT-R) ScoreDelayed recall - Baseline6.88 number of correct figures recalledStandard Deviation 2.84
Let's Move ProgramBrief Visual Memory Test - Revised (BVMT-R) ScoreTotal recall - Baseline16.97 number of correct figures recalledStandard Deviation 7.02
Let's Move ProgramBrief Visual Memory Test - Revised (BVMT-R) ScoreDelayed recall - T1 ( 13-15 weeks post baseline)7.59 number of correct figures recalledStandard Deviation 2.42
Let's Move ProgramBrief Visual Memory Test - Revised (BVMT-R) ScoreTotal recall - T3 ( 56-58 weeks post baseline)17.47 number of correct figures recalledStandard Deviation 7.17
Let's Move ProgramBrief Visual Memory Test - Revised (BVMT-R) ScoreDelayed recall - T2 (28-30 weeks post baseline)7.84 number of correct figures recalledStandard Deviation 2.81
Let's Move ProgramBrief Visual Memory Test - Revised (BVMT-R) ScoreDelayed recall - T3 ( 56-58 weeks post baseline)7.01 number of correct figures recalledStandard Deviation 2.88
Let's Move ProgramBrief Visual Memory Test - Revised (BVMT-R) ScoreTotal recall - T1 ( 13-15 weeks post baseline)19.99 number of correct figures recalledStandard Deviation 5.96
Let's Flex ProgramBrief Visual Memory Test - Revised (BVMT-R) ScoreDelayed recall - T3 ( 56-58 weeks post baseline)6.29 number of correct figures recalledStandard Deviation 3.25
Let's Flex ProgramBrief Visual Memory Test - Revised (BVMT-R) ScoreDelayed recall - T2 (28-30 weeks post baseline)7.67 number of correct figures recalledStandard Deviation 2.79
Let's Flex ProgramBrief Visual Memory Test - Revised (BVMT-R) ScoreTotal recall - Baseline15.97 number of correct figures recalledStandard Deviation 4.2
Let's Flex ProgramBrief Visual Memory Test - Revised (BVMT-R) ScoreTotal recall - T1 ( 13-15 weeks post baseline)17.16 number of correct figures recalledStandard Deviation 4.59
Let's Flex ProgramBrief Visual Memory Test - Revised (BVMT-R) ScoreTotal recall - T2 (28-30 weeks post baseline)18.18 number of correct figures recalledStandard Deviation 5.69
Let's Flex ProgramBrief Visual Memory Test - Revised (BVMT-R) ScoreTotal recall - T3 ( 56-58 weeks post baseline)16.23 number of correct figures recalledStandard Deviation 7.36
Let's Flex ProgramBrief Visual Memory Test - Revised (BVMT-R) ScoreDelayed recall - Baseline6.51 number of correct figures recalledStandard Deviation 2.58
Let's Flex ProgramBrief Visual Memory Test - Revised (BVMT-R) ScoreDelayed recall - T1 ( 13-15 weeks post baseline)6.77 number of correct figures recalledStandard Deviation 2.03
Primary

Category Fluency Test Score

The category fluency test requires participants to state out load the names of as many animals as possible within 60-seconds. Results are total number of animals named.

Time frame: Baseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 ( 56-58 weeks post baseline)

Population: Some participants did not complete the form or completed the incorrect forms and could not be included in the analysis.

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramCategory Fluency Test ScoreT3 (56-58 weeks post baseline)19.22 Number of correct animals namedStandard Deviation 4.7
Let's Move ProgramCategory Fluency Test ScoreT2 (28-30 weeks post baseline)20.24 Number of correct animals namedStandard Deviation 4.38
Let's Move ProgramCategory Fluency Test ScoreBaseline19.97 Number of correct animals namedStandard Deviation 4.96
Let's Move ProgramCategory Fluency Test ScoreT1 (13-15 weeks post baseline)19.87 Number of correct animals namedStandard Deviation 4.35
Let's Flex ProgramCategory Fluency Test ScoreT1 (13-15 weeks post baseline)17.63 Number of correct animals namedStandard Deviation 6.59
Let's Flex ProgramCategory Fluency Test ScoreBaseline18.89 Number of correct animals namedStandard Deviation 6.03
Let's Flex ProgramCategory Fluency Test ScoreT2 (28-30 weeks post baseline)17.82 Number of correct animals namedStandard Deviation 6.26
Let's Flex ProgramCategory Fluency Test ScoreT3 (56-58 weeks post baseline)17.13 Number of correct animals namedStandard Deviation 5.53
Primary

Coding Test Score

The coding test requires writing the corresponding symbol associated with a letter from a key provided. As many responses as possible are completed in the 120 second time limit. Results presented are the total number of correct responses (possible score range 0-135).

Time frame: Baseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 ( 56-58 weeks post baseline)

Population: The number analyzed includes participants who were able to complete each study visit.

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramCoding Test ScoreBaseline46.07 number of correct responsesStandard Deviation 14.64
Let's Move ProgramCoding Test ScoreT1 (13-15 weeks post baseline)45.31 number of correct responsesStandard Deviation 16.14
Let's Move ProgramCoding Test ScoreT2 (28-30 weeks post baseline)47.89 number of correct responsesStandard Deviation 17.32
Let's Move ProgramCoding Test ScoreT3 (56-58 weeks post baseline)50.11 number of correct responsesStandard Deviation 16.41
Let's Flex ProgramCoding Test ScoreT3 (56-58 weeks post baseline)47.23 number of correct responsesStandard Deviation 14.93
Let's Flex ProgramCoding Test ScoreBaseline45.69 number of correct responsesStandard Deviation 15.44
Let's Flex ProgramCoding Test ScoreT2 (28-30 weeks post baseline)42.84 number of correct responsesStandard Deviation 15.19
Let's Flex ProgramCoding Test ScoreT1 (13-15 weeks post baseline)43.13 number of correct responsesStandard Deviation 14.58
Primary

Digit Span Test Score

The digit span test is a performance based test that requires repeating an increasing span of digits that are provided verbally by the examiner. The test includes trials of repeating digits in the same order presented by the examiner, in the reverse order of that presented by the examiner, and in ascending sequence. Scores range from 0 to 48. Higher score correlates with better outcome.

Time frame: Baseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 ( 56-58 weeks post baseline)

Population: The number analyzed includes participants who were able to complete each study visit.

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramDigit Span Test ScoreT3 ( 56-58 weeks post baseline)23.86 number of correct digitsStandard Deviation 6.32
Let's Move ProgramDigit Span Test ScoreT1 (13-15 weeks post baseline)24.32 number of correct digitsStandard Deviation 5.16
Let's Move ProgramDigit Span Test ScoreBaseline23.19 number of correct digitsStandard Deviation 5.63
Let's Move ProgramDigit Span Test ScoreT2 (28-30 weeks post baseline)23.86 number of correct digitsStandard Deviation 6.62
Let's Flex ProgramDigit Span Test ScoreBaseline21.67 number of correct digitsStandard Deviation 5.56
Let's Flex ProgramDigit Span Test ScoreT3 ( 56-58 weeks post baseline)21.27 number of correct digitsStandard Deviation 5.56
Let's Flex ProgramDigit Span Test ScoreT2 (28-30 weeks post baseline)21.76 number of correct digitsStandard Deviation 5.84
Let's Flex ProgramDigit Span Test ScoreT1 (13-15 weeks post baseline)22.41 number of correct digitsStandard Deviation 4.72
Primary

Finger Tapping Test Score

The finger tapping test a fine motor speed requires tapping a lever with the index finger as quickly as possible. Trials with the dominant and non-dominant hand are completed.

Time frame: Baseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 ( 56-58 weeks post baseline)

Population: The number analyzed includes participants who were able to complete each study visit.

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramFinger Tapping Test ScoreDominant hand - Baseline36.21 SecondsStandard Deviation 8.13
Let's Move ProgramFinger Tapping Test ScoreDominant hand -T1 ( 13-15 weeks post baseline)39.34 SecondsStandard Deviation 10.47
Let's Move ProgramFinger Tapping Test ScoreDominant hand -T2 ( 28-30 weeks post baseline)38.19 SecondsStandard Deviation 8.98
Let's Move ProgramFinger Tapping Test ScoreDominant hand -T2 ( 56-58 weeks post baseline)38.82 SecondsStandard Deviation 9.57
Let's Move ProgramFinger Tapping Test ScoreNondominant hand - Baseline34.85 SecondsStandard Deviation 8.29
Let's Move ProgramFinger Tapping Test ScoreNondominant hand -T1 ( 13-15 weeks post baseline)36.59 SecondsStandard Deviation 8.32
Let's Move ProgramFinger Tapping Test ScoreNondominant hand -T2 ( 28-30 weeks post baseline)35.94 SecondsStandard Deviation 8.05
Let's Move ProgramFinger Tapping Test ScoreNondominant hand -T2 ( 56-58 weeks post baseline)36.91 SecondsStandard Deviation 8.36
Let's Flex ProgramFinger Tapping Test ScoreNondominant hand -T2 ( 56-58 weeks post baseline)31.94 SecondsStandard Deviation 7.39
Let's Flex ProgramFinger Tapping Test ScoreDominant hand - Baseline32.83 SecondsStandard Deviation 9.89
Let's Flex ProgramFinger Tapping Test ScoreNondominant hand - Baseline33.29 SecondsStandard Deviation 10.09
Let's Flex ProgramFinger Tapping Test ScoreDominant hand -T1 ( 13-15 weeks post baseline)33.9 SecondsStandard Deviation 11.37
Let's Flex ProgramFinger Tapping Test ScoreNondominant hand -T2 ( 28-30 weeks post baseline)34.53 SecondsStandard Deviation 11.61
Let's Flex ProgramFinger Tapping Test ScoreDominant hand -T2 ( 28-30 weeks post baseline)34.31 SecondsStandard Deviation 8.72
Let's Flex ProgramFinger Tapping Test ScoreNondominant hand -T1 ( 13-15 weeks post baseline)33.98 SecondsStandard Deviation 9.51
Let's Flex ProgramFinger Tapping Test ScoreDominant hand -T2 ( 56-58 weeks post baseline)33.13 SecondsStandard Deviation 6.92
Primary

Grooved Pegboard Test Score

The Grooved Pegboard Test requires the placing of grooved pegs into a same-shaped hole as quickly as possible, once with the dominant hand and once with the non-dominant hand.

Time frame: Baseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 ( 56-58 weeks post baseline)

Population: The number analyzed includes participants who were able to complete each study visit.

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramGrooved Pegboard Test ScoreDominant Hand - Baseline100.26 SecondsStandard Deviation 52.08
Let's Move ProgramGrooved Pegboard Test ScoreNondominant Hand - Baseline111.97 SecondsStandard Deviation 48.88
Let's Move ProgramGrooved Pegboard Test ScoreDominant Hand -T2 (28-30 weeks post baseline)90.81 SecondsStandard Deviation 32.85
Let's Move ProgramGrooved Pegboard Test ScoreNondominant Hand - T1 ( 13-15 weeks post baseline)110.63 SecondsStandard Deviation 43.35
Let's Move ProgramGrooved Pegboard Test ScoreDominant Hand - T1 ( 13-15 weeks post baseline)91.49 SecondsStandard Deviation 26.16
Let's Move ProgramGrooved Pegboard Test ScoreNondominant Hand -T2 (28-30 weeks post baseline)108.75 SecondsStandard Deviation 50.43
Let's Move ProgramGrooved Pegboard Test ScoreDominant Hand -T3 (56-58 weeks post baseline)89.99 SecondsStandard Deviation 34.03
Let's Move ProgramGrooved Pegboard Test ScoreNondominant Hand -T3 (56-58 weeks post baseline)101.04 SecondsStandard Deviation 46.31
Let's Flex ProgramGrooved Pegboard Test ScoreDominant Hand -T3 (56-58 weeks post baseline)92.45 SecondsStandard Deviation 29.37
Let's Flex ProgramGrooved Pegboard Test ScoreDominant Hand - Baseline103.46 SecondsStandard Deviation 44.52
Let's Flex ProgramGrooved Pegboard Test ScoreDominant Hand - T1 ( 13-15 weeks post baseline)101.94 SecondsStandard Deviation 30.38
Let's Flex ProgramGrooved Pegboard Test ScoreDominant Hand -T2 (28-30 weeks post baseline)101.78 SecondsStandard Deviation 35.76
Let's Flex ProgramGrooved Pegboard Test ScoreNondominant Hand -T3 (56-58 weeks post baseline)112.5 SecondsStandard Deviation 41.98
Let's Flex ProgramGrooved Pegboard Test ScoreNondominant Hand - Baseline118.67 SecondsStandard Deviation 56.29
Let's Flex ProgramGrooved Pegboard Test ScoreNondominant Hand - T1 ( 13-15 weeks post baseline)120.42 SecondsStandard Deviation 37.18
Let's Flex ProgramGrooved Pegboard Test ScoreNondominant Hand -T2 (28-30 weeks post baseline)119.06 SecondsStandard Deviation 43.12
Primary

Hopkins Verbal Learning Test (HVLT) - Revised Score

The HVLT-Revised is a list learning task requiring the respondent to recall as many words as possible from a list of 12 words provided orally by the examiner. There is a learning trial, a delayed recall trial, and a recognition trial. Results show HVLT Total recall (Total number if words recalled over 3 trials) and HVLT Delayed recall (Total number of words recalled after 25 minute delay).

Time frame: Baseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 ( 56-58 weeks post baseline)

Population: Some participants did not complete the form or completed the incorrect forms and could not be included in the analysis.

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramHopkins Verbal Learning Test (HVLT) - Revised ScoreDelayed recall - Baseline6.65 Number of correct words recalledStandard Deviation 2.57
Let's Move ProgramHopkins Verbal Learning Test (HVLT) - Revised ScoreTotal recall - Baseline6.65 Number of correct words recalledStandard Deviation 2.57
Let's Move ProgramHopkins Verbal Learning Test (HVLT) - Revised ScoreTotal recall - T1 ( 13-15 weeks post baseline)6.87 Number of correct words recalledStandard Deviation 2.37
Let's Move ProgramHopkins Verbal Learning Test (HVLT) - Revised ScoreTotal recall - T2 (28-30 weeks post baseline)6.56 Number of correct words recalledStandard Deviation 2.68
Let's Move ProgramHopkins Verbal Learning Test (HVLT) - Revised ScoreTotal recall - T3 ( 56-58 weeks post baseline)5.93 Number of correct words recalledStandard Deviation 2.6
Let's Move ProgramHopkins Verbal Learning Test (HVLT) - Revised ScoreDelayed recall - T1 ( 13-15 weeks post baseline)6.87 Number of correct words recalledStandard Deviation 2.37
Let's Move ProgramHopkins Verbal Learning Test (HVLT) - Revised ScoreDelayed recall - T2 (28-30 weeks post baseline)6.56 Number of correct words recalledStandard Deviation 2.68
Let's Move ProgramHopkins Verbal Learning Test (HVLT) - Revised ScoreDelayed recall - T3 ( 56-58 weeks post baseline)5.93 Number of correct words recalledStandard Deviation 2.6
Let's Flex ProgramHopkins Verbal Learning Test (HVLT) - Revised ScoreDelayed recall - T1 ( 13-15 weeks post baseline)6.65 Number of correct words recalledStandard Deviation 2.17
Let's Flex ProgramHopkins Verbal Learning Test (HVLT) - Revised ScoreDelayed recall - T2 (28-30 weeks post baseline)7 Number of correct words recalledStandard Deviation 2.25
Let's Flex ProgramHopkins Verbal Learning Test (HVLT) - Revised ScoreTotal recall - T3 ( 56-58 weeks post baseline)6.35 Number of correct words recalledStandard Deviation 2.68
Let's Flex ProgramHopkins Verbal Learning Test (HVLT) - Revised ScoreTotal recall - Baseline6.46 Number of correct words recalledStandard Deviation 2.4
Let's Flex ProgramHopkins Verbal Learning Test (HVLT) - Revised ScoreDelayed recall - Baseline6.46 Number of correct words recalledStandard Deviation 2.4
Let's Flex ProgramHopkins Verbal Learning Test (HVLT) - Revised ScoreTotal recall - T1 ( 13-15 weeks post baseline)6.65 Number of correct words recalledStandard Deviation 2.17
Let's Flex ProgramHopkins Verbal Learning Test (HVLT) - Revised ScoreDelayed recall - T3 ( 56-58 weeks post baseline)6.35 Number of correct words recalledStandard Deviation 2.68
Let's Flex ProgramHopkins Verbal Learning Test (HVLT) - Revised ScoreTotal recall - T2 (28-30 weeks post baseline)7 Number of correct words recalledStandard Deviation 2.25
Primary

Instrumental Activities of Daily Living (IADL) Test Score

The Instrumental Activities of Daily Living (IADL) Test is a self-report measure assessing the amount of assistance, if any, required to do day-to-day tasks necessary to live independently. A summary score ranges from 0 (low function, dependent) to 8 (high function, independent) for women and 0 through 5 for men to avoid potential gender bias). Higher scores indicate worse performance in instrumental activities activities of daily living.

Time frame: Baseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 (56-58 weeks post baseline)

Population: The number analyzed includes participants who were able to complete each study visit.

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramInstrumental Activities of Daily Living (IADL) Test ScoreBaseline7.95 Score on a scaleStandard Deviation 0.19
Let's Move ProgramInstrumental Activities of Daily Living (IADL) Test ScoreT1 (13-15 weeks post baseline)7.96 Score on a scaleStandard Deviation 0.24
Let's Move ProgramInstrumental Activities of Daily Living (IADL) Test ScoreT2 (28-30 weeks post baseline)7.83 Score on a scaleStandard Deviation 0.65
Let's Move ProgramInstrumental Activities of Daily Living (IADL) Test ScoreT3 (56-58 weeks post baseline)7.89 Score on a scaleStandard Deviation 0.44
Let's Flex ProgramInstrumental Activities of Daily Living (IADL) Test ScoreT3 (56-58 weeks post baseline)7.71 Score on a scaleStandard Deviation 0.76
Let's Flex ProgramInstrumental Activities of Daily Living (IADL) Test ScoreBaseline7.86 Score on a scaleStandard Deviation 0.66
Let's Flex ProgramInstrumental Activities of Daily Living (IADL) Test ScoreT2 (28-30 weeks post baseline)7.93 Score on a scaleStandard Deviation 0.25
Let's Flex ProgramInstrumental Activities of Daily Living (IADL) Test ScoreT1 (13-15 weeks post baseline)7.9 Score on a scaleStandard Deviation 0.3
Primary

Letter Fluency Assessed by Change in FAS Test Score

The FAS test requires stating out loud as many words that begin with the assigned letter (F, A, and S) as possible within 60-seconds. Results represent total number of words stated for F,A & S combined.

Time frame: Baseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 ( 56-58 weeks post baseline)

Population: The number analyzed includes participants who were able to complete each study visit.

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramLetter Fluency Assessed by Change in FAS Test ScoreBaseline35.91 number of correct wordsStandard Deviation 10.67
Let's Move ProgramLetter Fluency Assessed by Change in FAS Test ScoreT1 ( 13-15 weeks post baseline)38.51 number of correct wordsStandard Deviation 11.48
Let's Move ProgramLetter Fluency Assessed by Change in FAS Test ScoreT2 (28-30 weeks post baseline)37.26 number of correct wordsStandard Deviation 11.18
Let's Move ProgramLetter Fluency Assessed by Change in FAS Test ScoreT3 ( 56-58 weeks post baseline)38.24 number of correct wordsStandard Deviation 11.93
Let's Flex ProgramLetter Fluency Assessed by Change in FAS Test ScoreT3 ( 56-58 weeks post baseline)35.4 number of correct wordsStandard Deviation 13.96
Let's Flex ProgramLetter Fluency Assessed by Change in FAS Test ScoreBaseline31.44 number of correct wordsStandard Deviation 8.64
Let's Flex ProgramLetter Fluency Assessed by Change in FAS Test ScoreT2 (28-30 weeks post baseline)34.33 number of correct wordsStandard Deviation 11.01
Let's Flex ProgramLetter Fluency Assessed by Change in FAS Test ScoreT1 ( 13-15 weeks post baseline)31.28 number of correct wordsStandard Deviation 9.1
Primary

NIH Toolbox

Computerized cognitive tests developed and distributed by the NIH. Tests include Pattern Comparison Processing Speed Test, Picture Vocabulary Test, Reading Recognition Test, Dimensional Change Card Sort Test, Flanker Inhibitory Control and Attention Test, Picture Sequence Memory Test, List Sorting Working Memory Test, and Oral Symbol Digit Test

Time frame: Baseline, Post Intervention (Up to 58 weeks)

Population: In order to reduce participant burden, the NIH toolbox neurocognitive tests were not administered because was redundant with the outcomes measured by the other cognitive tests.

Primary

Stroop Color and Word Test Score

The Stroop Color and Word Test is a performance-based test of executive function and inhibitory responding. The participant is presented with a page with the words red, blue, and green printed 100 times in (20 words in 5 columns). Each word is printed in a different color of ink than the target word (e.g, the word red is printed in blue ink). Participants read the color of ink in which the word is printed as quickly are possible within a time limit. The correct number within the time limit is the score. Raw scores (unadjusted for age and education) range from 0-100.

Time frame: Baseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 ( 56-58 weeks post baseline)

Population: The number analyzed includes participants who were able to complete each study visit.

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramStroop Color and Word Test ScoreT2 (28-30 weeks post baseline)33.09 number of correct responsesStandard Deviation 8.72
Let's Move ProgramStroop Color and Word Test ScoreBaseline31.17 number of correct responsesStandard Deviation 8.13
Let's Move ProgramStroop Color and Word Test ScoreT3 ( 56-58 weeks post baseline)33.44 number of correct responsesStandard Deviation 8.74
Let's Move ProgramStroop Color and Word Test ScoreT1 (13-15 weeks post baseline)32.87 number of correct responsesStandard Deviation 8.85
Let's Flex ProgramStroop Color and Word Test ScoreT3 ( 56-58 weeks post baseline)31.77 number of correct responsesStandard Deviation 7.83
Let's Flex ProgramStroop Color and Word Test ScoreT2 (28-30 weeks post baseline)30.39 number of correct responsesStandard Deviation 9.5
Let's Flex ProgramStroop Color and Word Test ScoreT1 (13-15 weeks post baseline)30.69 number of correct responsesStandard Deviation 6.64
Let's Flex ProgramStroop Color and Word Test ScoreBaseline28.89 number of correct responsesStandard Deviation 7.59
Primary

Symbol Span Test Score

The subtest assesses visual working memory using novel visual stimuli. A series of abstract symbols on a page are shown briefly. Then the symbols are to be selected from an array of symbols in the same order they were presented on the previous page. This performance based test measures storage and manipulation of visual details in working memory. Score range from 0-36. Higher score correlates with better outcome.

Time frame: Baseline, 3 months, 6 months and 12 months Post Intervention

Population: The number analyzed includes participants who were able to complete each study visit.

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramSymbol Span Test ScoreBaseline17.19 score on a scaleStandard Deviation 6.11
Let's Move ProgramSymbol Span Test Score3 months post-intervention19.56 score on a scaleStandard Deviation 5.76
Let's Move ProgramSymbol Span Test Score6 months post-intervention19.17 score on a scaleStandard Deviation 7.16
Let's Move ProgramSymbol Span Test Score12 months post-intervention19.56 score on a scaleStandard Deviation 5.76
Let's Flex ProgramSymbol Span Test Score12 months post-intervention16.78 score on a scaleStandard Deviation 5.58
Let's Flex ProgramSymbol Span Test ScoreBaseline15.33 score on a scaleStandard Deviation 5.89
Let's Flex ProgramSymbol Span Test Score6 months post-intervention17.18 score on a scaleStandard Deviation 6.38
Let's Flex ProgramSymbol Span Test Score3 months post-intervention16.78 score on a scaleStandard Deviation 5.58
Primary

Trail Making Test Score

The Trail Making Test is a performance based test of visual attention and task switching. It consists of two parts in which the subject is instructed to connect circles as possible while still maintaining accuracy. Trails A subtest requires the connection in sequence of 25 circles labeled by numbers. Trails B requires the connection in sequence of 25 circles labeled by alternating numbers and letters (1-A-2-B-3-C). The score on the test is the time in seconds that it takes to complete. Higher scores (i.e., time) indicate poorer performance.

Time frame: Baseline, T1 (13-15 weeks post baseline), T2 (28-30 weeks post baseline), T3 ( 56-58 weeks post baseline)

Population: The number analyzed includes participants who were able to complete each study visit.

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramTrail Making Test ScorePart A - T2 (28-30 weeks post baseline)34.73 secondsStandard Deviation 17.54
Let's Move ProgramTrail Making Test ScorePart B - T2 (28-30 weeks post baseline)117.91 secondsStandard Deviation 82.97
Let's Move ProgramTrail Making Test ScorePart A - Baseline35.84 secondsStandard Deviation 14.11
Let's Move ProgramTrail Making Test ScorePart A -T1 (13-15 weeks post baseline)33.62 secondsStandard Deviation 12.39
Let's Move ProgramTrail Making Test ScorePart A - T3 ( 56-58 weeks post baseline)33.29 secondsStandard Deviation 12.49
Let's Move ProgramTrail Making Test ScorePart B - Baseline113.7 secondsStandard Deviation 62.29
Let's Move ProgramTrail Making Test ScorePart B -T1 (13-15 weeks post baseline)109.51 secondsStandard Deviation 58.68
Let's Move ProgramTrail Making Test ScorePart B - T3 ( 56-58 weeks post baseline)115.76 secondsStandard Deviation 94.08
Let's Flex ProgramTrail Making Test ScorePart B -T1 (13-15 weeks post baseline)142.26 secondsStandard Deviation 93.74
Let's Flex ProgramTrail Making Test ScorePart A - T2 (28-30 weeks post baseline)39.03 secondsStandard Deviation 15.62
Let's Flex ProgramTrail Making Test ScorePart A - T3 ( 56-58 weeks post baseline)36.23 secondsStandard Deviation 12.92
Let's Flex ProgramTrail Making Test ScorePart B - T2 (28-30 weeks post baseline)164.58 secondsStandard Deviation 128.75
Let's Flex ProgramTrail Making Test ScorePart B - Baseline137.95 secondsStandard Deviation 86.58
Let's Flex ProgramTrail Making Test ScorePart A - Baseline37.74 secondsStandard Deviation 20.08
Let's Flex ProgramTrail Making Test ScorePart B - T3 ( 56-58 weeks post baseline)145.28 secondsStandard Deviation 115.38
Let's Flex ProgramTrail Making Test ScorePart A -T1 (13-15 weeks post baseline)35.58 secondsStandard Deviation 16.51
Secondary

Brain-derived Neurotrophic Factor (BDNF) Level

BDNF is a protein that occurs naturally in the hippocampus, cortex, and basal forebrain-areas vital to learning, memory, and higher thinking; an increase in BDNF in animal models and humans is thought to enhance neurogenesis. BDNF is reported as in picogram per milliliter (pg/mL).

Time frame: Baseline, Post Intervention (Up to 58 weeks)

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramBrain-derived Neurotrophic Factor (BDNF) LevelT3 (56-58 weeks)2347.42 pg/mLStandard Deviation 2877.94
Let's Move ProgramBrain-derived Neurotrophic Factor (BDNF) LevelT2 (28-30 weeks)3014.45 pg/mLStandard Deviation 3941.81
Let's Move ProgramBrain-derived Neurotrophic Factor (BDNF) LevelT1 (13-15 weeks)3142.40 pg/mLStandard Deviation 3378.12
Let's Move ProgramBrain-derived Neurotrophic Factor (BDNF) LevelBaseline2436.95 pg/mLStandard Deviation 2376.96
Let's Flex ProgramBrain-derived Neurotrophic Factor (BDNF) LevelT1 (13-15 weeks)2963.97 pg/mLStandard Deviation 2678.83
Let's Flex ProgramBrain-derived Neurotrophic Factor (BDNF) LevelBaseline2910.17 pg/mLStandard Deviation 2571.53
Let's Flex ProgramBrain-derived Neurotrophic Factor (BDNF) LevelT2 (28-30 weeks)2895.28 pg/mLStandard Deviation 2316.84
Let's Flex ProgramBrain-derived Neurotrophic Factor (BDNF) LevelT3 (56-58 weeks)4877.86 pg/mLStandard Deviation 7766.09
Secondary

Flow-Mediated Dilatation (FMD)

Flow-mediated dilatation (FMD) is a measure of endothelial function; the measure of % FMD at 60 seconds reflects arterial relaxation time after cuff deflation.

Time frame: Baseline, T2 (28-30 weeks post baseline)

Population: The number analyzed includes participants who were able to complete each study visit.

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramFlow-Mediated Dilatation (FMD)Baseline4.62 percent dilationStandard Deviation 3.2
Let's Move ProgramFlow-Mediated Dilatation (FMD)T2 (28-30 weeks post baseline)4.31 percent dilationStandard Deviation 2.1
Let's Flex ProgramFlow-Mediated Dilatation (FMD)Baseline5.64 percent dilationStandard Deviation 3.8
Let's Flex ProgramFlow-Mediated Dilatation (FMD)T2 (28-30 weeks post baseline)5.48 percent dilationStandard Deviation 2.6
Secondary

Interleukin 6 (IL-6) Level

IL-6 is a pro-inflammatory cytokine known to contribute to the pathogenesis of risk of cardiovascular disease (CVD) and cognitive impairment (CI) through inflammation and promotion of endothelial vascular dysfunction. IL-6 is measured by enzyme-linked immunosorbent assay (ELISA) and reported as in picograms per deciliter (pg/dL). Higher concentrations of IL-6 raise congenital heart defect risk.

Time frame: Baseline, T1 (13-15 Weeks), T2 (28-30 weeks), T3 (56-58 weeks)

Population: Lab assays were completed at each time-point based on the participants availability and those samples that were good for lab processing.

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramInterleukin 6 (IL-6) LevelBaseline2.5 pg/mlStandard Deviation 3.09
Let's Move ProgramInterleukin 6 (IL-6) LevelT1 (13-15 wks)2.5 pg/mlStandard Deviation 3.2
Let's Move ProgramInterleukin 6 (IL-6) LevelT2 (28-30 wks)2.3 pg/mlStandard Deviation 2.06
Let's Move ProgramInterleukin 6 (IL-6) LevelT3 (56-58 wks)2.5 pg/mlStandard Deviation 2.4
Let's Flex ProgramInterleukin 6 (IL-6) LevelT3 (56-58 wks)7.2 pg/mlStandard Deviation 17.6
Let's Flex ProgramInterleukin 6 (IL-6) LevelBaseline5.4 pg/mlStandard Deviation 12.5
Let's Flex ProgramInterleukin 6 (IL-6) LevelT2 (28-30 wks)4.7 pg/mlStandard Deviation 9.9
Let's Flex ProgramInterleukin 6 (IL-6) LevelT1 (13-15 wks)5.1 pg/mlStandard Deviation 10.9
Secondary

Soluble Cluster of Differentiation 14 (sCD14) Level

Soluble Cluster of Differentiation 14 (sCD14) is a marker of monocyte activation, is associated with neurocognitive impairment and HIV-associated neurocognitive disorders (HANDs) and higher mortality in persons living with HIV.

Time frame: Baseline, T1 (13-15 weeks), T2 (28-30 weeks), T3 (56 -58 weeks)

Population: Lab assays were completed at each time-point based on the participants availability and those samples that were good for lab processing.

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramSoluble Cluster of Differentiation 14 (sCD14) LevelBaseline2306.0 pg/mlStandard Deviation 711.94
Let's Move ProgramSoluble Cluster of Differentiation 14 (sCD14) LevelT1 (13-15 weeks)2315.5 pg/mlStandard Deviation 748.5
Let's Flex ProgramSoluble Cluster of Differentiation 14 (sCD14) LevelBaseline2373.1 pg/mlStandard Deviation 525.3
Let's Flex ProgramSoluble Cluster of Differentiation 14 (sCD14) LevelT1 (13-15 weeks)2342.6 pg/mlStandard Deviation 672.5
Secondary

Tumor Necrosis Factor Alpha (TNF-alpha) Level

TNFR1 membrane bound receptors that have been shown to bind TNF alpha. Activation of TNFR1 mediates the proinflammatory properties of TNF alpha.

Time frame: Baseline, T1 (13-15 wks), T2 (28-30 wks), T3 (56-58 wks)

Population: Lab assays were completed at each time-point based on the participants availability and those samples that were good for lab processing.

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramTumor Necrosis Factor Alpha (TNF-alpha) LevelT3 (56-58 wks)1.6 pg/mlStandard Deviation 0.82
Let's Move ProgramTumor Necrosis Factor Alpha (TNF-alpha) LevelT1 (13-15 wks)1.7 pg/mlStandard Deviation 1.08
Let's Move ProgramTumor Necrosis Factor Alpha (TNF-alpha) LevelBaseline1.6 pg/mlStandard Deviation 1.1
Let's Move ProgramTumor Necrosis Factor Alpha (TNF-alpha) LevelT2 (28-30 wks)1.6 pg/mlStandard Deviation 1.03
Let's Flex ProgramTumor Necrosis Factor Alpha (TNF-alpha) LevelBaseline1.6 pg/mlStandard Deviation 0.6
Let's Flex ProgramTumor Necrosis Factor Alpha (TNF-alpha) LevelT3 (56-58 wks)1.71 pg/mlStandard Deviation 0.8
Let's Flex ProgramTumor Necrosis Factor Alpha (TNF-alpha) LevelT2 (28-30 wks)1.75 pg/mlStandard Deviation 0.86
Let's Flex ProgramTumor Necrosis Factor Alpha (TNF-alpha) LevelT1 (13-15 wks)1.71 pg/mlStandard Deviation 0.74
Other Pre-specified

Beck Depression Inventory-II (BDI-II) Score

BDI-II is a 21-question multiple-choice self-report inventory, one of the most widely used instruments for measuring the severity of depression. Each answer being scored on a scale value of 0 to 3. Scores range from 0-63. Interpretation: 0 through 9 indicate no or minimal depression; scores from 10 through 18 indicate mild to moderate depression; scores from 19 through 29 indicate moderate to severe depression; and scores from 30 through 63 indicate severe depression.

Time frame: Baseline, T2 (28-30 weeks post baseline), T3 (56-58 weeks post baseline)

Population: The number analyzed includes participants who were able to complete each study visit.

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramBeck Depression Inventory-II (BDI-II) ScoreBaseline6.95 score on a scaleStandard Deviation 5
Let's Move ProgramBeck Depression Inventory-II (BDI-II) ScoreT2 (28-30 weeks post baseline)8.28 score on a scaleStandard Deviation 7
Let's Move ProgramBeck Depression Inventory-II (BDI-II) ScoreT3 (56-58 weeks post baseline)7.17 score on a scaleStandard Deviation 4.45
Let's Flex ProgramBeck Depression Inventory-II (BDI-II) ScoreBaseline8.64 score on a scaleStandard Deviation 6
Let's Flex ProgramBeck Depression Inventory-II (BDI-II) ScoreT2 (28-30 weeks post baseline)10.79 score on a scaleStandard Deviation 4
Let's Flex ProgramBeck Depression Inventory-II (BDI-II) ScoreT3 (56-58 weeks post baseline)11.13 score on a scaleStandard Deviation 4.45
Other Pre-specified

Exercise Regimen as Assessed by the Community Healthy Activities Model Program for Seniors (CHAMPS) Questionnaire

The 41-item Community Healthy Activities Model Program for Seniors evaluates weekly duration of various types of physical activity among older adults including light, moderate and vigorous intensity levels. The activity is assessed by hours per week using 6 categories less than 1 hour to 9 or more hours. The values presented below are hours participants indicated they spent in moderate intensity activity levels at the 3 time points over the past 4 weeks. Guidelines suggest 150 minutes (2.5 hours) per week in moderate intensity physical activity, below this number is considered sedentary. We measure change from baseline in time spent in moderate intensity exercise.

Time frame: Baseline, T2 (28-30 weeks post baseline), T3 (56-58 weeks post baseline)

Population: The number analyzed includes participants who were able to complete each study visit.

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramExercise Regimen as Assessed by the Community Healthy Activities Model Program for Seniors (CHAMPS) QuestionnaireBaseline9.85 hours per weekStandard Deviation 10.4
Let's Move ProgramExercise Regimen as Assessed by the Community Healthy Activities Model Program for Seniors (CHAMPS) QuestionnaireT3 (56-58 weeks post baseline)9.72 hours per weekStandard Deviation 4.45
Let's Move ProgramExercise Regimen as Assessed by the Community Healthy Activities Model Program for Seniors (CHAMPS) QuestionnaireT2 (28-30 weeks post baseline)12.1 hours per weekStandard Deviation 7.56
Let's Flex ProgramExercise Regimen as Assessed by the Community Healthy Activities Model Program for Seniors (CHAMPS) QuestionnaireBaseline12.13 hours per weekStandard Deviation 10.4
Let's Flex ProgramExercise Regimen as Assessed by the Community Healthy Activities Model Program for Seniors (CHAMPS) QuestionnaireT3 (56-58 weeks post baseline)8.96 hours per weekStandard Deviation 4.45
Let's Flex ProgramExercise Regimen as Assessed by the Community Healthy Activities Model Program for Seniors (CHAMPS) QuestionnaireT2 (28-30 weeks post baseline)8.59 hours per weekStandard Deviation 7.56
Other Pre-specified

Pittsburgh Sleep Quality Index (PSQI) Score

The Pittsburgh Sleep Quality Index (PSQI) is a 19-item measure of the quality and patterns of sleep among adults. Scoring is based on a 0 to 3 Likert scale. The global score is 21; total possible score ranges from 0 to 21. The higher the score the worse the sleep quality.

Time frame: Baseline, T2 (28-30 weeks post baseline), T3 (56-58 weeks post baseline)

Population: The number analyzed includes participants who were able to complete each study visit.

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramPittsburgh Sleep Quality Index (PSQI) ScoreT3 (56-58 weeks post baseline)7.32 score on a scaleStandard Deviation 4.45
Let's Move ProgramPittsburgh Sleep Quality Index (PSQI) ScoreBaseline7.97 score on a scaleStandard Deviation 8
Let's Move ProgramPittsburgh Sleep Quality Index (PSQI) ScoreT2 (28-30 weeks post baseline)7.38 score on a scaleStandard Deviation 3.87
Let's Flex ProgramPittsburgh Sleep Quality Index (PSQI) ScoreT3 (56-58 weeks post baseline)8.55 score on a scaleStandard Deviation 4.45
Let's Flex ProgramPittsburgh Sleep Quality Index (PSQI) ScoreBaseline7.46 score on a scaleStandard Deviation 6
Let's Flex ProgramPittsburgh Sleep Quality Index (PSQI) ScoreT2 (28-30 weeks post baseline)8.13 score on a scaleStandard Deviation 3.87
Other Pre-specified

Six-minute Walk Test

Measure of functional capacity or submaximal exercise. Scores reflect distance walked in feet for 6 minutes duration. This is an exploratory outcome.

Time frame: Baseline, T2 (28-30 weeks post baseline), T3 (56-58 weeks post baseline)

Population: The number analyzed includes participants who were able to complete each study visit.

ArmMeasureGroupValue (MEAN)Dispersion
Let's Move ProgramSix-minute Walk TestBaseline1465.58 distance walked in feetStandard Deviation 63.58
Let's Move ProgramSix-minute Walk TestT2 (28-30 weeks post baseline)1469.3 distance walked in feetStandard Deviation 261.75
Let's Move ProgramSix-minute Walk TestT3 (56-58 weeks post baseline)1497.68 distance walked in feetStandard Deviation 243.54
Let's Flex ProgramSix-minute Walk TestBaseline1475.07 distance walked in feetStandard Deviation 63.58
Let's Flex ProgramSix-minute Walk TestT2 (28-30 weeks post baseline)1478.11 distance walked in feetStandard Deviation 261.75
Let's Flex ProgramSix-minute Walk TestT3 (56-58 weeks post baseline)1475.35 distance walked in feetStandard Deviation 243.54
Other Pre-specified

V02 Max Rate

V02 max is the maximum rate of oxygen consumption as measured during incremental exercise using the Balke treadmill test. This is an exploratory outcome.

Time frame: Baseline

Population: Number analyzed includes participants that completed the baseline visit.

ArmMeasureValue (MEAN)Dispersion
Let's Move ProgramV02 Max Rate20.48 mL/kg/minStandard Deviation 19.5
Let's Flex ProgramV02 Max Rate20.67 mL/kg/minStandard Deviation 20.3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026